Quality of life EQ-5D results from the aethera trial: A phase 3 study of brentuximab vedotin consolidation following autologous stem cell transplant for HL

Category Primary study
JournalHaematologica
Year 2015
This article has no abstract
Epistemonikos ID: 7007d9d504475b45a61dc7ab0c6687b2eb72e778
First added on: Feb 07, 2025